Correlating quantitative susceptibility mapping with cognitive decline in Alzheimer's disease

Brain. 2017 Aug 1;140(8):2069-2072. doi: 10.1093/brain/awx167.

Abstract

This scientific commentary refers to ‘Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline’ by Ayton et al., (doi:10.1093/brain/awx137).

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Alzheimer Disease*
  • Amyloid beta-Peptides
  • Cognitive Dysfunction*
  • Humans
  • Neuropsychological Tests

Substances

  • Amyloid beta-Peptides